Thus, bispecific Abs binding CD3 or Vγ9 on γδ T cells and HER2/neu on PDAC cells enhanced the cytotoxicity of γδ T cells via granzyme B and perforin release and led to a reduced tumor growth in a subcutaneous PDAC Xenograft model [219]. This evidence concerns the gene ERBB2 and neoplasm.